Literature DB >> 29657674

United States Preventive Services Task Force Overstates Cosmetic Harms of Skin Cancer Screening.

Joseph F Sobanko1,2,3,4, Kimberly Shao1,2,3,4, Rebecca L Pearl1,2,3,4, Sancy Leachman1,2,3,4.   

Abstract

The United States Preventive Services Task Force (USPSTF) 2016 recommendation for skin cancer screening in asymptomatic healthy adults concluded that current evidence is "insufficient to assess the balance and harms of visual skin examination." One contributing factor leading to the insufficient grade was a concern for cosmetic harms resulting from unnecessary biopsies or excisions. This commentary briefly highlights the pertinent studies and currently accepted methods for pigmented lesion biopsy. Reviewing these data will permit clinicians to more thoroughly analyze the USPSTF statement and might assist in routine assessment and management of suspicious pigmented lesions in adult patients.

Entities:  

Keywords:  U.S. Preventive Task Force; melanoma; skin biopsy; skin cancer; skin cancer screening

Year:  2018        PMID: 29657674      PMCID: PMC5891089     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN: 1941-2789


  18 in total

1.  Scarring occurs at a critical depth of skin injury: precise measurement in a graduated dermal scratch in human volunteers.

Authors:  Christopher S J Dunkin; Jonathon M Pleat; Patrick H Gillespie; Michael P H Tyler; Anthony H N Roberts; D Angus McGrouther
Journal:  Plast Reconstr Surg       Date:  2007-05       Impact factor: 4.730

2.  To scoop or not to scoop: the diagnostic and therapeutic utility of the scoop-shave biopsy for pigmented lesions.

Authors:  Gary Mendese; Mary Maloney; Jeremy Bordeaux
Journal:  Dermatol Surg       Date:  2014-10       Impact factor: 3.398

3.  The Case for Skin Cancer Screening With Total-Body Skin Examinations.

Authors:  Vinayak K Nahar; Jonathan E Mayer; Jane M Grant-Kels
Journal:  JAMA Oncol       Date:  2016-08-01       Impact factor: 31.777

4.  What the USPSTF "Insufficient" Skin Cancer Screening Recommendation Means for Primary Care Clinicians and Dermatologists.

Authors:  Susan M Swetter; Alan C Geller; Allan C Halpern
Journal:  JAMA Dermatol       Date:  2016-09-01       Impact factor: 10.282

5.  Total-Body Examination vs Lesion-Directed Skin Cancer Screening.

Authors:  Isabelle Hoorens; Katrien Vossaert; Lore Pil; Barbara Boone; Sofie De Schepper; Katia Ongenae; Lieven Annemans; Ines Chevolet; Lieve Brochez
Journal:  JAMA Dermatol       Date:  2016-01       Impact factor: 10.282

6.  Psychological characteristics and outcomes of elective cosmetic surgery patients: the influence of cosmetic surgery history.

Authors:  Nicki A Dowling; Alun C Jackson; Roberta J Honigman; Kate L Francis
Journal:  Plast Surg Nurs       Date:  2011 Oct-Dec

7.  Skin Cancer-The Importance of Prevention.

Authors:  Eleni Linos; Kenneth A Katz; Graham A Colditz
Journal:  JAMA Intern Med       Date:  2016-10-01       Impact factor: 21.873

8.  The rate of melanoma transection with various biopsy techniques and the influence of tumor transection on patient survival.

Authors:  Mohsin Mir; C Stanley Chan; Farhan Khan; Bhuvaneswari Krishnan; Ida Orengo; Theodore Rosen
Journal:  J Am Acad Dermatol       Date:  2012-09-08       Impact factor: 11.527

9.  Effect of biopsy type on outcomes in the treatment of primary cutaneous melanoma.

Authors:  Jane K Mills; Ian White; Brian Diggs; Jeanine Fortino; John T Vetto
Journal:  Am J Surg       Date:  2013-05       Impact factor: 2.565

10.  Frequency of excisions and yields of malignant skin tumors in a population-based screening intervention of 360,288 whole-body examinations.

Authors:  Annika Waldmann; Sandra Nolte; Alan C Geller; Alexander Katalinic; Martin A Weinstock; Beate Volkmer; Ruediger Greinert; Eckhard W Breitbart
Journal:  Arch Dermatol       Date:  2012-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.